google ads

Liver CT Appearances

 

 


Common Bile Duct (CBD) Cholangiocarcinoma CT Findings

  • Thickened, enhancing bile duct wall
  • Papillary or nodular mass
  • Intrahepatic bile duct dilatation
  • Staging:
    • T1: Tumor confined to bile duct histologically   
    • T2: Tumor beyond the wall of bile duct   
    • T3: Tumor invades liver, GB, pancreas, but no involvement of celiac axis, or the superior mesenteric artery   
    • T4: Tumor involves the celiac axis or the superior mesenteric artery 

CBD Cholangiocarcinoma CT Findings

Other Information About Common Bile Duct (CBD) Cholangiocarcinoma

Etiology:

  • Unknown
  • Increased risk in patients who smoke or have diabetes

Epidemiology:

  • Typically presents after age 65

Presentation:

  • Jaundice
  • Itchy skin
  • Abdominal pain
  • Weight loss
  • Dark urine
  • Nausea and/or vomiting
  • Fever

Prognosis:

  • The 5-year relative survival rates for intrahepatic bile duct cancer are:
    • Localized: 23%
    • Regional: 9%
    • Distant: 3%
    • All SEER stages combined: 9%
  • The 5-year relative survival rates for extrahepatic bile duct cancer are:
    • Localized: 18%
    • Regional: 18%
    • Distant: 2%
    • All SEER stages combined: 11%

Related Pearls: Cholangiocarcinoma

Privacy Policy

Copyright © 2025 The Johns Hopkins University, The Johns Hopkins Hospital, and The Johns Hopkins Health System Corporation. All rights reserved.